- Home
- CSBR vs FRD Comparison
CSBR vs FRD Comparison
Compare CSBR & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- FRD
- Stock Information
- Founded
- CSBR 1985
- FRD 1965
- Country
- CSBR United States
- FRD United States
- Employees
- CSBR N/A
- FRD N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- FRD Steel/Iron Ore
- Sector
- CSBR Health Care
- FRD Industrials
- Exchange
- CSBR Nasdaq
- FRD Nasdaq
- Market Cap
- CSBR 113.0M
- FRD 122.0M
- IPO Year
- CSBR 1986
- FRD N/A
- Fundamental
- Price
- CSBR $7.90
- FRD $17.15
- Analyst Decision
- CSBR Strong Buy
- FRD
- Analyst Count
- CSBR 1
- FRD 0
- Target Price
- CSBR $12.00
- FRD N/A
- AVG Volume (30 Days)
- CSBR 36.4K
- FRD 24.0K
- Earning Date
- CSBR 03-11-2025
- FRD 06-10-2025
- Dividend Yield
- CSBR N/A
- FRD 0.93%
- EPS Growth
- CSBR N/A
- FRD N/A
- EPS
- CSBR 0.46
- FRD 0.81
- Revenue
- CSBR $58,591,000.00
- FRD $447,616,000.00
- Revenue This Year
- CSBR $15.11
- FRD N/A
- Revenue Next Year
- CSBR $7.80
- FRD N/A
- P/E Ratio
- CSBR $17.27
- FRD $21.09
- Revenue Growth
- CSBR 19.03
- FRD N/A
- 52 Week Low
- CSBR $3.60
- FRD $12.24
- 52 Week High
- CSBR $11.99
- FRD $19.47
- Technical
- Relative Strength Index (RSI)
- CSBR 43.84
- FRD 62.84
- Support Level
- CSBR $7.61
- FRD $16.38
- Resistance Level
- CSBR $8.86
- FRD $17.22
- Average True Range (ATR)
- CSBR 0.69
- FRD 0.98
- MACD
- CSBR 0.04
- FRD 0.25
- Stochastic Oscillator
- CSBR 44.28
- FRD 98.20
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.